Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3432954 | 1.00 | LMNA (0.31) | LMNA | |
| SCHEMBL9446877 | 0.98 | — | — | |
| SCHEMBL10948995 | 0.98 | LMNA (0.32) | LMNA | |
| SCHEMBL9774510 | 0.87 | — | — | |
| SCHEMBL9127392 | 0.87 | — | — | |
| SCHEMBL11783987 | 0.85 | LMNA (0.30) | LMNA | |
| SCHEMBL10591158 | 0.82 | — | — | |
| SCHEMBL3433017 | 0.77 | — | — | |
| SCHEMBL3435200 | 0.77 | — | — | |
| SCHEMBL9446874 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100055067-A1 | PERFLUOROCARBON CONJUGATE AS A BLOOD SUBSTITUTE | SNU R&DB FOUNDATION | 2010-03-04 | — | — | US | claimed |
| US-20100055067-A1 | PERFLUOROCARBON CONJUGATE AS A BLOOD SUBSTITUTE | SNU R&DB FOUNDATION | 2010-03-04 | — | — | US | disclosed |
| US-5262442-A | Fluosol for injection for oxygen transport | ALPHA THERAPEUTIC CORPORATION (US) | 1993-11-16 | — | — | US | disclosed |
| EP-0548601-A1 | Process for rapid thawing and storage of frozen fluorocarbon emulsion, and resultant product | ALPHA THERAPEUTIC CORPORATION (US) | 1993-06-30 | — | — | EP | disclosed |
| EP-0282948-B1 | STABLE FLUOROCARBON AQUEOUS EMULSIONS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1993-01-20 | — | — | EP | disclosed |
| EP-0282949-B1 | CONCENTRATED STABLE FLUORCHEMICAL AQUEOUS EMULSIONS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1992-05-20 | — | — | EP | disclosed |
| US-5114932-A | Hyperosmolar oxyreplete hemosubstitute | RUNGE THOMAS M (US) | 1992-05-19 | — | — | US | disclosed |
| EP-0220153-B1 | A NUTRITIVE EMULSION HAVING OXYGEN-TRANSPORTING PROPERTIES, AND PROCESS FOR ITS PREPARATION | Kabi Pharmacia AB (SE) | 1991-07-24 | — | — | EP | disclosed |
| US-4895876-A | ARTIFICIAL BLOOD, ORGAN PRESERVATION | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1990-01-23 | — | — | US | disclosed |
| US-4866096-A | Stable fluorochemical aqueous emulsions | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1989-09-12 | — | — | US | disclosed |
| EP-0282948-A2 | Stable fluorocarbon aqueous emulsions | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1988-09-21 | — | — | EP | disclosed |
| EP-0282949-A2 | Concentrated stable fluorchemical aqueous emulsions | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1988-09-21 | — | — | EP | disclosed |
| EP-0220153-A1 | A nutritive emulsion having oxygen-transporting properties, and process for its preparation | Kabi Pharmacia AB (SE) | 1987-04-29 | — | — | EP | disclosed |
| EP-0033402-B1 | PERFUSATE FOR PRESERVING ORGAN TO BE TRANSPLANTED AND PRESERVING METHOD | The Green Cross Corporation (JP) | 1983-09-07 | — | — | EP | disclosed |
| US-4285928-A | AN EMULSION OF AN X-RAY CONTRAST AGENT AND A MIXTURE OF PERFLUORO COMPOUNDS HAVING OXYGEN-CARRYING ABILITIES | Wada, Juro (JP) | 1981-08-25 | — | — | US | disclosed |
| EP-0033402-A1 | Perfusate for preserving organ to be transplanted and preserving method | The Green Cross Corporation (JP) | 1981-08-12 | — | — | EP | disclosed |
| US-4252827-A | PERFLUORODECALIN AND PERFLUOROTRIPROPYLAMINE; ETHYLENE OXIDE-PROPYLENE OXIDE COPOLYMER; PHOSPHOLIPID; FATTY ACID, SALT OR MONOGLYCERIDE | THE GREEN CROSS CORPORATION (JP) | 1981-02-24 | — | — | US | disclosed |
| US-4186253-A | RINGER'S SOLUTION WITH INCREASED POTASSIUM ION, ALBUMIN, PERFLUOROCARBON COMPOUND, EMULSIFIER | THE GREEN CROSS CORPORATION (JP) | 1980-01-29 | — | — | US | disclosed |
| US-3993581-A | WITH A PHOSPHOLIPID AS EMULSIFIER AND A FATTY ACID, ALKALI METAL SALT OR ITS MONOGLYCERIDE AS AN ADJUVANT | THE GREEN CROSS CORPORATION (JA) | 1976-11-23 | — | — | US | disclosed |
| US-3962439-A | PERFLUOROCARBON COMPOUNDS | THE GREEN CROSS CORPORATION (JA) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100055067-A1 | PERFLUOROCARBON CONJUGATE AS A BLOOD SUBSTITUTE | FGB, CD47, PF4 | LMNA 2421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.